Searched for
USV PHARMACEUTICALS
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- USV Pharma leads race to buy 85% stake in Wellbeing Nutrition at Rs 1,600 crore valuationThe Mumbai-based brand, owned by Nutritionlab, counts Hindustan Unilever and Fireside Ventures among its early backers. HUL and Fireside — ...
- Leena Tiwari: Meet the billionaire owner of India's costliest flatsLeena Tewari, chairperson of USV, made headlines with the purchase of luxury apartments in Mumbai for Rs 639 crore, India's most expensive ...
- Who is Leena Tewari? Owner of India's costliest flats worth over Rs 700 crore, spanning 22,572 sq ft in WorliLeena Tewari, USV Pharmaceuticals chairperson, purchases luxury Mumbai apartments for Rs 639 crore. This deal sets a new real estate record...
- Indian pharma market grew 12.1% in August, AWACS reportThe wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on ...
- Indian pharma market grew 14.1% in July, AIOCD reportThe fastest growing categories are respiratory which grew at 22.3%, gynaecology - 24%, chemotherapy - 28.4%, urology - 22.5%, ophthalmic - ...
- USV in talks with Novartis to buy Jalra Trademark for Rs. 200 CroreMumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...
- Novartis India ex-chief Jawed Zia joins rival AbbottAbbott in the second largest drug maker in India but it competes with Novartis in several therapy areas like cardiovascular, and diabetes. ...
- 4 pharma companies under CCI scanner over price-fixingNovartis, Abbott among cos served notice for alleged cartelisation in diabetic drug.
- CCI starts probe on alleged price fixing of key anti diabetic drugsEmcure also did not respond to an email query as of press time while USV remained unreachable for a comment.
- I-T probes pharmaceutical company's nexus with doctorsThe department, in the past few days, carried out raids at 20 premises of USV India and three reputed doctors in Mumbai, and one each in Na...
- Anti-diabetic drug cartel issue reaches CCI, Health MinistryCCI had been informed about the cartelisation allegations in a letter dated Feb 27, ET reported earlier. At that time, Novartis had denied ...
- NPPA to look into diabetes drug price-fixing allegationsVildagliptin is a proprietary drug of Novartis sold under the brand Galvus and comes under a new class of anti-diabetic drugs known as DPP ...
- Code for pharma firms to have more teethThe voluntary code, initially applicable till June 2015, has been given four extensions despite the department repeatedly admitting it wasn...
- Pharma cos offer freebies to doctors, violate code: MPThe CAG, in a report in 2015, criticised the Central Board of Direct Taxes for allowing promotional expenses by pharma companies as deducti...
- Indian pharma market crosses Rs 1,00,000 crore mark: IMS HealthIn its monthly review of the local market, IMS Health said in its note titled Market Reflections that Indian companies took over three-four...
- Diabetes drug ban to help companies like USV, Sun Pharma, LupinIn the wake of a government ban on top-selling diabetes drug, pioglitazone , the volumes are expected to shift to other classes such as fir...
- Diabetic drug co USV takes a shot at injectiblesUSV, the largest anti-diabetic drug maker in India, is planning to enter the injectibles segment. The company will inaugurate its first inj...
- Now, USV looks for generic gains in a tough US marketIn spite of challenging market conditions, more and more Indian pharma companies are entering the US generic drugs market.
Load More
